Shire edges higher on better-than-expected earnings, though sales miss
Related Biotechnology, Pharmaceutical and Healthcare News
Ireland-headquartered Shire saw its shares close up 1.5% at 3,576.57 pence on Friday, after the company…
Original Article: Shire edges higher on better-than-expected earnings, though sales miss
NEXT ARTICLE
More From BioPortfolio on "Shire edges higher on better-than-expected earnings, though sales miss"